ArticleOncology and therapy2022

ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer.

Ana Ortega-Franco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.